A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.

One company holds a near-total monopoly on it.

Colin Love Biography and Net Worth

COO of Replimune Group

Colin Love is the Chief Operating Officer and co-founder of Replimune. Colin most recently provided consultancy support to a range of companies from small gene therapy start-ups to large established biotech companies. He has over 30 years experience developing and launching biotechnology products and led development teams for Medeva, Serono and Amersham, prior to joining BioVex. Colin was SVP of Product Development at BioVex from 2000 until it was acquired by Amgen in 2011. Following the acquisition, he remained at Amgen as VP of R&D Operations working on T-VEC until it was approved in 2015.

What is Colin A. Love's net worth?: The estimated net worth of Colin A. Love is at least $9.48 million as of May 16th, 2024. Dr. Love owns 777,345 shares of Replimune Group stock worth more than $9,475,836 as of November 13th. This net worth estimate does not reflect any other investments that Dr. Love may own. Additionally, Dr. Love receives a salary of $419,370.00 as COO at Replimune Group. Learn More about Colin A. Love's net worth.
How old is Colin A. Love?: Dr. Love is currently 66 years old. There are 9 older executives and no younger executives at Replimune Group. Learn More on Colin A. Love's age.
What is Colin A. Love's salary?: As the COO of Replimune Group, Inc., Dr. Love earns $419,370.00 per year. There are 4 executives that earn more than Dr. Love. The highest earning executive at Replimune Group is Mr. Philip Astley-Sparke F.S.A., CEO & Director, who commands a salary of $1,070,000.00 per year. Learn More on Colin A. Love's salary.
How do I contact Colin A. Love?: The corporate mailing address for Dr. Love and other Replimune Group executives is 500 Unicorn Park, WOBURN MA, 01801. Replimune Group can also be reached via phone at (781) 222-9600 and via email at [email protected]. Learn More on Colin A. Love's contact information.
Has Colin A. Love been buying or selling shares of Replimune Group?: Colin A. Love has not been actively trading shares of Replimune Group during the last ninety days. Most recently, Colin Love sold 17,615 shares of the business's stock in a transaction on Thursday, May 16th. The shares were sold at an average price of $6.47, for a transaction totalling $113,969.05. Following the completion of the sale, the chief operating officer now directly owns 777,345 shares of the company's stock, valued at $5,029,422.15. Learn More on Colin A. Love's trading history.
Who are Replimune Group's active insiders?: Replimune Group's insider roster includes Robert Coffin (Insider), Pamela Esposito (Insider), and Colin Love (COO). Learn More on Replimune Group's active insiders.
Are insiders buying or selling shares of Replimune Group?: During the last year, insiders at the sold shares 9 times. They sold a total of 123,849 shares worth more than $883,363.29. The most recent insider tranaction occured on August, 16th when CFO Emily Luisa Hill sold 8,938 shares worth more than $90,988.84. Insiders at Replimune Group own 8.8% of the company. Learn More about insider trades at Replimune Group.
Information on this page was last updated on 8/16/2024.

Colin A. Love Insider Trading History at Replimune Group

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/16/2024	Sell	17,615	$6.47	$113,969.05	777,345
5/16/2023	Sell	10,775	$18.05	$194,488.75	794,960
5/16/2022	Sell	6,324	$14.59	$92,267.16	765,735
10/18/2021	Sell	12,711	$29.58	$375,991.38
10/15/2021	Sell	17,289	$30.42	$525,931.38
9/15/2021	Sell	30,000	$31.23	$936,900.00
8/16/2021	Sell	30,000	$29.93	$897,900.00	808,509
7/15/2021	Sell	30,000	$32.02	$960,600.00
6/15/2021	Sell	30,000	$34.10	$1,023,000.00	878,009
4/15/2021	Sell	30,000	$30.63	$918,900.00	898,509
3/15/2021	Sell	30,000	$33.54	$1,006,200.00	905,142
2/16/2021	Sell	30,000	$36.32	$1,089,600.00	927,904
1/19/2021	Sell	7,857	$42.46	$333,608.22	974,324
1/15/2021	Sell	22,143	$43.51	$963,441.93	974,324
12/9/2020	Sell	30,000	$43.75	$1,312,500.00	1,005,824
11/16/2020	Sell	15,000	$44.91	$673,650.00	1,021,224
8/17/2020	Sell	15,000	$23.44	$351,600.00	1,042,488
11/6/2019	Sell	22,500	$16.92	$380,700.00
10/31/2019	Sell	11,250	$17.02	$191,475.00
9/23/2019	Sell	11,250	$17.05	$191,812.50

Colin A. Love Buying and Selling Activity at Replimune Group

Replimune Group Company Overview

Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development of oncolytic immunotherapies to treat cancer. The company's proprietary tumor-directed oncolytic immunotherapy product candidates are designed and intended to activate the immune system against cancer. Its lead product candidate is RP1, a selectively replicating version of HSV-1 that expresses GALV-GP R(-) and human GM-CSF, which is in Phase I/II clinical trials for a range of solid tumors; and that has completed Phase II clinical trials for treating cutaneous squamous cell carcinoma. The company is also developing RP2, which is in Phase I clinical trials to express an anti-CTLA-4 antibody-like protein to block the inhibition of the immune response otherwise caused by CTLA-4; and RP3 that is in Phase I clinical trial to express immune-activating proteins that stimulate T cells. Replimune Group, Inc. was founded in 2015 and is headquartered in Woburn, Massachusetts.

Today's Range

Now: $12.19

$11.45

$12.60

50 Day Range

MA: $11.42

$10.34

$12.70

2 Week Range

Now: $12.19

$4.92

$12.97

Volume

460,407 shs

Average Volume

1,040,354 shs

Market Capitalization

$832.82 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.19

War on Elon Escalates…

From Porter & Company | Ad

One company holds a near-total monopoly on it.

Colin Love Biography and Net Worth

What is Colin A. Love's net worth?

How old is Colin A. Love?

What is Colin A. Love's salary?

How do I contact Colin A. Love?

Has Colin A. Love been buying or selling shares of Replimune Group?

Who are Replimune Group's active insiders?

Are insiders buying or selling shares of Replimune Group?